Opportunity Information: Apply for RFA CA 22 043
Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required) is a National Institutes of Health (NIH) discretionary grant opportunity (Funding Opportunity Number RFA-CA-22-043) designed to move the field forward on helping adolescents stop using tobacco. The program focuses specifically on developing, testing, implementing, and evaluating behavioral tobacco cessation interventions for youth in the mid- to late-adolescent period, roughly ages 14 through 20. The emphasis on this window reflects the fact that it is a high-risk developmental stage when tobacco use patterns can become more entrenched, making timely, well-designed cessation strategies especially important.
The FOA supports research that is intervention-oriented and behavioral in nature, and it explicitly requires a clinical trial, meaning applicants should be proposing studies that prospectively assign human participants to one or more interventions to evaluate effects on health-related biomedical or behavioral outcomes. In practical terms, the announcement is looking for rigorous intervention research that does more than describe the problem: it should generate evidence about what actually helps adolescents quit, under what conditions, and how those approaches can be delivered in real-world settings. Projects can span the full pipeline from early intervention development through efficacy/effectiveness testing and, importantly, implementation and evaluation, signaling interest not only in whether an intervention can work, but whether it can be adopted, delivered well, and sustained in settings where adolescents can realistically be reached.
The funding mechanism is an NIH R01 research project grant, which typically supports multi-year, investigator-initiated research with clearly defined aims, a strong scientific premise, and a robust plan for recruitment, intervention delivery, outcomes measurement, and analysis appropriate for a clinical trial. The opportunity lists an award ceiling of $3,150,000, indicating the maximum total amount expected per award under this announcement (with actual budgets depending on the scope and allowable costs). The CFDA numbers associated with the opportunity are 93.279 and 93.393, and the activity areas are health and education, consistent with cessation interventions that often involve both clinical/public health outcomes and school or community delivery contexts.
Eligibility is broad and includes many types of U.S. governmental entities and organizations, such as state, county, city or township governments; special district governments; and independent school districts. Public and state-controlled institutions of higher education and private institutions of higher education are eligible, as are federally recognized Native American tribal governments, public housing authorities/Indian housing authorities, and Native American tribal organizations that are not federally recognized tribal governments. The FOA also allows nonprofit organizations (both 501(c)(3) and non-501(c)(3), excluding higher education institutions in those categories), for-profit organizations other than small businesses, and small businesses. In addition, the announcement explicitly calls out other eligible applicants that NIH wants to encourage, including Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; tribal governments other than federally recognized; and even non-domestic (non-U.S.) entities (foreign organizations), expanding the range of institutions that can lead or participate in this work.
Key administrative details include the sponsoring agency (NIH), the original posting date (Creation Date: 2022-10-03), and the original application due date (Original Closing Date: 2023-10-16). The listing notes “Expected Awards:” but does not provide a number in the source data provided, which usually means the number of awards may depend on the availability of funds and the merit of applications received.
Overall, this FOA is aimed at strengthening the evidence base for adolescent tobacco cessation by funding clinical trial-driven behavioral intervention research targeted to 14- to 20-year-olds, with attention not only to developing and testing interventions but also to the practical realities of implementing and evaluating them in the settings and systems that serve adolescents.Apply for RFA CA 22 043
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279, 93.393.
- This funding opportunity was created on 2022-10-03.
- Applicants must submit their applications by 2023-10-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $3,150,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Targeting Inflammasomes in Substance Abuse and HIV (R21 Clinical Trial Not Allowed)
Previous opportunity: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 22 043
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 22 043) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed) Apply for RFA CA 22 052 Funding Number: RFA CA 22 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 053 Funding Number: RFA CA 22 053 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) Apply for RFA CA 22 051 Funding Number: RFA CA 22 051 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional) Apply for RFA DA 23 061 Funding Number: RFA DA 23 061 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed) Apply for RFA CA 22 057 Funding Number: RFA CA 22 057 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional) Apply for RFA DA 23 062 Funding Number: RFA DA 23 062 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) Apply for RFA CA 22 056 Funding Number: RFA CA 22 056 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) Apply for PAR 23 034 Funding Number: PAR 23 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| AHEAD (Advancing Head and Neck Cancer Early Detection Research) (U01 Clinical Trial Not Allowed) Apply for RFA DE 23 013 Funding Number: RFA DE 23 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) Apply for RFA DA 24 007 Funding Number: RFA DA 24 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 23 021 Funding Number: PAR 23 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) Apply for PAR 22 249 Funding Number: PAR 22 249 Agency: National Institutes of Health Category: Education, Health Funding Amount: $2,000,000 |
| Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) Apply for PAR 22 239 Funding Number: PAR 22 239 Agency: National Institutes of Health Category: Education, Health Funding Amount: $375,000 |
| Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed) Apply for RFA CA 23 018 Funding Number: RFA CA 23 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) Apply for PAR 23 041 Funding Number: PAR 23 041 Agency: National Institutes of Health Category: Education, Health Funding Amount: $125,000 |
| Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed) Apply for RFA CA 23 019 Funding Number: RFA CA 23 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) Apply for RFA DA 24 003 Funding Number: RFA DA 24 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Targeting Inflammasomes in Substance Abuse and HIV (R21 Clinical Trial Not Allowed) Apply for RFA DA 24 004 Funding Number: RFA DA 24 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Investigating the Effects of Addictive Substances on Brain Developmental Trajectories Using Innovative Scalable Methods for Quantification of Cell Identity, Lineage and Connectivity (R01 - Clinical Trial Not Allowed) Apply for RFA DA 23 036 Funding Number: RFA DA 23 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed) Apply for RFA CA 23 013 Funding Number: RFA CA 23 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 22 043", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
